Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, CPG

Media Advisory - Press conference - Quebec Government announcement regarding Giant Steps Autism Centre


MONTREAL, Aug. 30, 2021 /CNW Telbec/ - Giant Steps, a leader in autism and educational services, and the Angus Development Corporation are pleased to invite the media to a press conference in Montreal on August 31 at 10:30 a.m. with Mr. Jean-François Roberge, Minister of Education, Ms. Chantal Rouleau, Minister of Transport and Minister responsible for the Metropolis and the Montreal Region, and Mr. Charles Lafortune who will be the master of ceremony.

Media wishing to attend must do so in person. Following public health guidelines, the maximum number of journalists for this event is 16. In addition, only two cameras for all media and two photographers will be allowed on site (camera pool). Please note that journalists must bring their press card.

As a reminder, those attending the press conference must not have symptoms similar to those of COVID-19 or have been in contact with someone who has been diagnosed with the disease in the last 14 days. Those in attendance must follow wear a mask and adhere to physical distancing and other hygiene measures.

What?

Press Conference: Government of Quebec announcement regarding Giant Steps Autism Centre

When?

Tuesday, August 31, 2021 at 10:30 a.m.

Where?

Montreal - The exact address will be sent to you following your confirmation, the day before the event.

RSVP and interviews

In addition to the speakers at the press conference, the following people will be available on site for interviews:

Journalists wishing to attend the press conference must confirm their presence by email to  [email protected] or by phone at (450) 702-0339. 
Only those who have received confirmation of their registration will be able to attend. 
The exact address will be sent to you following your confirmation, the day before the event. Parking instructions will also be sent to you by email.

SOURCE Giant Steps


These press releases may also interest you

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: